IndraLab
Statements
sparser
"For heterogeneity analysis, AP2 methylation heterogeneity is associated with tumor size ( P < 0.01), CDH1 methylation heterogeneity is associated with lymph node metastasis ( P < 0.05), DACT2 methylation heterogeneity is associated with tumor size ( P < 0.01), HIN1 methylation heterogeneity is associated with tumor size and extra-thyroidal extension (all P < 0.01)."
sparser
"Among these five genes, DACT2 methylation is associated with gender, age, and tumor size (all P < 0.05), HIN1 methylation is associated with tumor size ( P < 0.05) and extra-thyroidal extension ( P < 0.01), RASSF1A methylation is associated with lymph node metastasis ( P < 0.01)."
sparser
"In particular as a special case with the GST approach ( xref ), HIN1, RASSF1A and TWIST methylation levels were significantly lower in basal-like subtype compared to luminal (p = 0.006, p < 0.0001 and p = 0.0006, respectively) or HER2 subtypes (p = 0.003, p = 0.048 and p = 0.009, respectively), whereas their methylation levels were found to be similar between luminal and HER2 subtypes (p > 0.999, p = 0.090 and p = >0.999, respectively)."
sparser
"Our observation of decreased mortality among very active women with APC or HIN1 methylation is counter to our a priori hypothesis of lowered risk of death among active women with unmethylated (active) tumor suppressor genes, although we did observe that in the highest RPA group, there was no statistical difference in the effect among APC methylated and unmethylated cases."